Ua puka mai kekahi ʻano hou a ʻoi aku ka maʻi maʻi a me ka weliweli o Omicron, i kapa ʻia i kēia manawa ʻo Omicron BA.2 subtype variant, he mea koʻikoʻi hoʻi akā ʻaʻole i kūkākūkā ʻia ma mua o ke kūlana ma Ukraine. (Meka a ka Lunahooponopono: Wahi a ka WHO, aia ka Omicron strain i ka spectrum b.1.1.529 a me kāna mau mamo ba.1, ba.1.1, ba.2 a me ba.3. ba.1 no ka hapa nui o nā maʻi, akā, ke piʻi nei nā maʻi ba.2.)
Ke manaʻoʻiʻo nei ʻo BUPA ʻo ka nui o ka volatility i nā mākeke honua i nā lā i hala iho nei ma muli o ka emi ʻana o ke kūlana ma Ukraine, a ʻo kekahi kumu ʻē aʻe ka ʻano hou o Omicron, kahi ʻano hou o ka maʻi maʻi i manaʻoʻiʻo ai ka ʻoihana e piʻi aʻe ana i ka pilikia. ʻOi aku ka nui o ka hopena macro ma ka hoʻokele waiwai honua ma mua o ke kūlana ma Ukraine.
Wahi a nā ʻike hou loa mai ke Kulanui o Tokyo ma Iapana, ʻaʻole wikiwiki wale ka ʻano subtype BA.2 i hoʻohālikelike ʻia me ka COVID-19 i kēia manawa, ʻo Omicron BA.1, akā hiki ke hoʻoulu i ka maʻi koʻikoʻi a ʻike ʻia e hiki ke pale. kekahi o nā mea kaua koʻikoʻi i loaʻa iā mākou e kūʻē i ka COVID-19.
Ua hoʻopili ka poʻe noiʻi i nā hamsters me nā maʻi BA.2 a me BA.1, i kēlā me kēia, a ʻike i ka poʻe i loaʻa i ka BA.2 ua maʻi a ua ʻoi aku ka nui o ka ʻeha o ka māmā. Ua ʻike ka poʻe noiʻi he hiki i ka BA.2 ke hoʻopuni i kekahi o nā antibodies i hana ʻia e ke kano a kūʻē i kekahi mau lāʻau lapaʻau.
Ua ʻōlelo ka poʻe noiʻi o ka hoʻokolohua, "ʻO nā hoʻokolohua neutralization e hōʻike ana ʻaʻole hana maikaʻi ka pale ʻana i ka maʻi maʻi i ka BA.2 e like me ka BA.1."
Ua hōʻike ʻia nā maʻi o ka BA.2 variant virus ma nā ʻāina he nui, a ua manaʻo ka World Health Organization i ka BA.2 ma kahi o 30 pakeneka ʻoi aku ka maʻi maʻi ma mua o ka BA.1 o kēia manawa, i loaʻa ma 74 mau ʻāina a me 47 mau mokuʻāina ʻo US.
ʻO kēia maʻi virus subvariant ka 90% o nā hihia hou a pau ma Denmark. Ua ʻike ʻo Denmark i kahi rebound hou i ka nui o nā hihia i make ma muli o ka maʻi me ka COVID-19.
ʻO nā ʻike mai ke Kulanui o Tokyo ma Iapana a me nā mea e hana nei ma Denmark ua makaʻala i kekahi mau loea honua.
Ua lawe ʻo Epidemiologist ʻo Dr. Eric Feigl-Ding i Twitter e kāhea aku i ka pono o ka WHO (World Health Organization) e haʻi i ka ʻano hou o Omicron BA.2 i kumu e hopohopo ai.
Ua ʻōlelo pū ʻo Maria Van Kerkhove, ke alakaʻi ʻenehana no ka coronavirus hou, ʻo BA.2 kahi ʻano hou o Omicron.
Ua ʻōlelo nā mea noiʻi.
"ʻOiai ua manaʻo ʻia ʻo BA.2 he ʻano mutant hou o Omicron, ʻokoʻa loa kona kaʻina genome mai BA.1, e hōʻike ana he ʻano virological ʻokoʻa ka BA.2 ma mua o BA.1."
Loaʻa i ka BA.1 a me ka BA.2 nā ʻano hoʻololi, ʻoi loa i nā ʻāpana koʻikoʻi o ka protein stinger viral. Ua ʻōlelo ʻo Jeremy Luban, he virologist ma ke Kula Lapaʻau o ke Kulanui o Massachusetts, ʻo BA.2 he pūʻulu holoʻokoʻa o nā mutations hou ʻaʻole i hoʻāʻo ʻia e kekahi.
Ua ʻōlelo ʻo Mads Albertsen, he bioinformatician ma ke Kulanui ʻo Aalborg ma Denmark, ʻo ka hoʻonui mau ʻana o ka BA.2 ma kekahi mau ʻāina e hōʻike ana he ʻoi aku ka maikaʻi o ka ulu ʻana ma mua o nā ʻano ʻē aʻe, me nā ʻano subtype ʻē aʻe o Omicron, e like me ka spectrum kaulana i kapa ʻia ʻo BA. 3.
ʻO kahi haʻawina o nā ʻohana 8,000 Denemaka i loaʻa i ka omicron e hōʻike ana i ka piʻi ʻana o ka maʻi BA.2 ma muli o nā kumu like ʻole. Ua ʻike nā mea noiʻi, ʻo Troels Lillebaek, he epidemiologist a me ka luna o ke Kōmike Denemaka no ka Risk Assessment of COVID-19 Variants, ʻo ka poʻe i hoʻomaʻamaʻa ʻole ʻia, pālua ʻelua a hoʻoikaika ʻia ka poʻe i loaʻa i ka maʻi BA.2 ma mua o ka BA.1 maʻi maʻi.
Akā, ua ʻōlelo ʻo Lillebaek, ʻoi aku ka paʻakikī o ka BA.2 ma kahi haʻahaʻa. ʻO ka maikaʻi o ka ulu ʻana o kēia ʻano ʻokoʻa ma mua o ka BA.1 ʻo ia ka mea hiki ke hoʻolōʻihi i ka piko o ka maʻi omicron, ma laila e hoʻonui ai i ka manawa o ka maʻi i ka poʻe ʻelemakule a me nā poʻe ʻē aʻe i ka pilikia nui no ka maʻi koʻikoʻi.
Akā aia kekahi wahi ʻālohilohi: ʻo nā antibodies i loko o ke koko o ka poʻe i loaʻa hou i ka maʻi omicron e hāʻawi pū ana i kahi palekana mai ka BA.2, ʻoi aku ka nui inā ua hoʻopaʻa ʻia lākou.
Ke hāpai nei kēia i kahi mea koʻikoʻi, wahi a University of Washington School of Medicine virologist Deborah Fuller, ʻoiai ʻo BA.2 ka mea i ʻoi aku ka maʻi maʻi a me ka pathogenic ma mua o Omicron, ʻaʻole paha ia e hoʻopau i ka nalu ʻoi aku ka pōʻino o nā maʻi COVID-19.
He mea koʻikoʻi ka maʻi, ʻōlelo ʻo ia, akā ʻo mākou nō kāna mau mea hoʻokipa. Aia nō mākou i ka heihei kūʻē i ka maʻi maʻi, ʻaʻole ia ka manawa no nā kaiāulu e hāpai i ka lula mask.
Ka manawa hoʻouna: Mar-14-2022